In an interview to CNBC-TV18, Amritanshu Khaitan, MD of Eveready India spoke about the results and his outlook for the company. The company is in the process of implementing certain price hikes in AA and AAA categories to mitigate the cost pressure which has impacted margins in Q4, he said.
first published: May 31, 2017 12:31 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty's weakness continue for the second straight day? | Opening Bell
A money superpower you have in your 20s, not in 40s
Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
Live: Will US-Venezuela tensions derail Nifty's upmove? | Oil stocks in focus | Opening Bell
